ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS Awards Three More Grants For Prevention Research; AHF Establishes Chair In Nutrition

November 14, 1980

DCT Board Committee Recommends Limited Start On In Vitro Screening Program

January 18, 1985

Program Announcements

July 25, 1986

In Brief: Radiologists Elect Officers, Award Medals; FDA Advisors Okay Test For Breast Cancer

September 29, 1995

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001

NCI Seeks Applications For Small Business Research Awards

February 28, 1997